Clinical Trials Sponsored by Alpharma ApS

Total 7395 results

AHS Cancer Control Alberta

Recruiting

Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (ACT-FAST)

Brain Metastases, Adult

Canada
AHS Cancer Control Alberta

Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

Cancer

Canada
AHS Cancer Control Alberta

Active, not recruiting

A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers (PRESTO)

Estrogen Receptor Positive Breast Cancer

Canada
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer

Czechia, Poland
AHS Cancer Control Alberta

Terminated

[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours

Renal Cell Carcinoma | Neuroendocrine Tumours

Canada
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer | Ovarian Cancer (OvCa)

Czechia, Poland, Germany
AHS Cancer Control Alberta

Completed

Breast Cancer and Exercise Trial in Alberta (BETA)

Breast Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Uveal Melanoma

Canada
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Prostate Cancer

Czechia
AHS Cancer Control Alberta

Unknown

A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors

Breast Cancer

Canada
AHS Cancer Control Alberta

Unknown

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Completed

Study of Tomotherapy in Patients With Benign Brain Tumour

Brain Neoplasms

Canada
AHS Cancer Control Alberta

Completed

Tomotherapy Treatment for Mesothelioma

Mesothelioma

Canada
AHS Cancer Control Alberta

Withdrawn

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Recurrent Glioblastoma

Canada
AHS Cancer Control Alberta

Terminated

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Prostate Cancer

Canada
AHS Cancer Control Alberta

Terminated

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Breast Cancer

Canada
AHS Cancer Control Alberta

Completed

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Healthy

Canada
AHS Cancer Control Alberta

Terminated

Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy

Cardiac Toxicity | Genetic Markers | Breast and Skin Motion

Canada
AHS Cancer Control Alberta

Withdrawn

TORI 104 Pre-Surgical Dasatinib

Breast Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL

Lymphoma

Canada
ATS Clinical Research
Allergan

Completed

Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows

Hypotrichosis

United States
AHS Cancer Control Alberta

Unknown

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Lung Neoplasm | Cell Hypoxia

Canada
AHS Cancer Control Alberta

Unknown

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Colorectal Cancer | Colorectal Carcinoma | Neoplasms, Colorectal

Canada
AHS Cancer Control Alberta

Not yet recruiting

PET/MRI in Rectal Cancer

Rectal Cancer
AHS Cancer Control Alberta

Recruiting

SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases

Colorectal Cancer | Liver Metastasis Colon Cancer

Canada
Tesu Saglik Teknolojileri A.S.

Recruiting

Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes

PreDiabetes

Turkey
AHS Cancer Control Alberta

Not yet recruiting

BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma (BIOSELECT)

Mycosis Fungoides

Canada
AHS Cancer Control Alberta

Recruiting

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

Cancer

Canada
AHS Cancer Control Alberta

Not yet recruiting

High Heated Humidity in Stem Cell Transplant

Autologous Stem Cell Transplant

Canada
AHS Cancer Control Alberta

Not yet recruiting

Steroid Sparing in Immune Related Hepatitis (irH)

Hepatitis Immune
AHS Cancer Control Alberta

Recruiting

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Glioblastoma Multiforme

Canada
AHS Cancer Control Alberta

Recruiting

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Brain Metastases

Canada
AHS Cancer Control Alberta

Recruiting

HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis (ATG2017)

Relapse | Graft-versus-host-disease

Canada
AHS Cancer Control Alberta

Recruiting

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Carcinoma, Neuroendocrine

Canada
AHS Cancer Control Alberta

Terminated

Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer

Metastatic Breast Cancer

Canada
AHS Cancer Control Alberta

Completed

iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Carcinoma

Canada
AHS Cancer Control Alberta

Terminated

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Bone Scan

Canada
AHS Cancer Control Alberta

Terminated

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate (PREMIUM)

Prostatic Neoplasm

Canada
AHS Cancer Control Alberta

Completed

Multi-Parametric Brain Cancer MRI

Brain Tumors

Canada
SOTIO a.s.

Completed

Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

Stage IV Non-small Cell Lung Cancer

Czechia, Slovakia
SOTIO a.s.

Completed

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Ovarian Cancer Recurrent

Czechia
AHS Cancer Control Alberta

Completed

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland (PET PRO)

Prostatic Neoplasms

Canada
Columbia University
ALS Association

Terminated

Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
AHS Cancer Control Alberta

Terminated

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Colon Cancer

Canada
AHS Cancer Control Alberta

Withdrawn

Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib

Fatigue | Renal Cell Cancer

Canada
AHS Cancer Control Alberta

Terminated

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy (CIPN)

Peripheral Neuropathy in Breast Cancer Patient

Canada
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
Emory University
ALS Association

Completed

Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) (NIPALS2013)

Amyotrophic Lateral Sclerosis (ALS)

United States

3

Subscribe